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1302Background: The quality of care and outcomes for people who experience stroke whilst
in hospital for another condition has not been previously studied in Australia. Aims: To
explore differences in long-term outcomes among patients with in-hospital events
treated in stroke units (SUs) compared to those managed in other hospital wards.
Methods: Forty-five hospitals participating in the Australian Stroke Clinical Registry
between January 2010 and December 2014 contributed data. Survival of all patients
with in-hospital stroke to 180 days after stroke and health-related quality of life, using
EQ-5D-3L among 73% eligible, were compared using multilevel, multivariable regres-
sion models. Models were adjusted for age, sex, index of relative socioeconomic disad-
vantage, ability to walk, stroke type, transfer from another hospital, and history of
stroke. Results: Among 20,786 stroke events, 1182 (5.1%) occurred in-hospital (median
age 77 years, 49% male). Patients with in-hospital stroke treated in SUs died less often
within 30 days (Hazard Ratio 0.56; 95% CI 0.39-0.81) than those not admitted to SUs.
Survivors reported similar health-related quality of life between 90 and 180 days com-
pared to those treated in other wards (coefficient = 0.01, 95% CI 0.06-0.09, P= .78).
Patients managed in SUs more often received recommended management (e.g. swal-
lowing screening). Conclusion: The benefits of SU care may extend to patients
experiencing in-hospital stroke. Validation, including accounting for potential residual
confounding factors, is required.
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Given the high prevalence of cardiovascular risk factors
among hospitalized patients, stroke can occur in a broad
range of patients while they are in hospital receiving man-
agement for another condition including major surgery.1
Stroke unit (SU) care, that includes co-located patients
within a hospital receiving specialized, interdisciplinary
management can significantly reduce death and disabil-
ity.2 Therefore, all patients with stroke should be treated
in SUs irrespective of age, stroke severity or type.3
Approximately, 4%-15% of patients experience a stroke
while in hospital for another condition (commonly termed
“in-hospital” stroke).4-6 Compared with patients present-
ing from the community, patients with in-hospital ische-
mic strokes have worse outcomes and receive less
evidence-based care,7 with very few treated in SUs.8 There
may be several justifiable reasons why patients with in-
hospital stroke are not managed in SUs. However, once
their primary condition has stabilized, management in the
SU to support rehabilitation from the effects of stroke is
important for reducing disability,7 as well as ensuring
commencement of secondary prevention therapies.
To our knowledge, evidence on the long-term outcome
of patients with in-hospital stroke is lacking. We aimed to
explore whether patients with in-hospital events had bet-
ter survival and health-related quality of life (HR-QoL)
within 180 days if managed in an SU, compared to other
wards, and to describe any potential explanatory factors
for the associations observed.
Methods
This was an observational study using data from the
Australian Stroke Clinical Registry (AuSCR) obtained
from 2010-2014. The AuSCR design has been detailed pre-
viously. In brief, the AuSCR is a voluntary, clinical quality
registry used in Australian hospitals to capture data on
consecutive patients admitted with stroke or transient
ischemic attack or events that occur in hospital.9 The
AuSCR commenced in 2009 and was initially funded via
research and educational grants, but is now mainly sup-
ported by state government grants (since 2012).
The majority of hospitals that contribute data to AuSCR
are public and located in the eastern (most densely popu-
lated) states.10 Cases are entered prospectively in the
AuSCR based on clinical diagnosis of stroke during the
admission. Case ascertainment is checked annually using
International Classification of Diseases (ICD)-10 discharge
codes obtained from the hospital administrative system
and compared to the cases entered in the registry at each
hospital (see Supplemental methods).
We included all episodes of ischemic, intracerebral
hemorrhage (ICH), and undetermined stroke for the anal-
yses. Transient ischemic attack was excluded. The AuSCR
includes a minimum dataset of personal information
(e.g. name, address), clinical data, process of careindicators, and outcomes (see below).9 Among individu-
als with multiple episodes of care registered within
90-180 days of an index event, only the first episode was
followed up. Annual linkage of AuSCR data to the
National Death Index ensures survival status is known
for all registrants.
Patient Characteristics
Patient characteristics included age, sex, country of
birth, and language spoken at home. The variable “able to
walk unaided” is used for assessing stroke severity in
AuSCR. It is a global measure of disability that is nor-
mally assessed at the time of hospital admission. How-
ever, for patients who experience their stroke when
already in hospital, this is assessed within the first
24 hours of this event. This simple measure has been vali-
dated by Counsell and colleagues (relative risk for 30-day
survival 1.63 95% CI 1.15-2.31)11; and we have found this
variable to be a reliable predictor of independence at time
of hospital discharge and for survival.12,13 Place of resi-
dence was used to derive the “index of relative socio-eco-
nomic advantage and disadvantage” (IRSAD) score for
each patient. The scores were divided into quintiles, with
quintile 1 representing the most disadvantaged patients.
Clinician classification of stroke type (ischemic, ICH,
undetermined, as well as whether the event occurred in
hospital) and the ICD-10 discharge codes are both col-
lected in AuSCR.9 For our analyses, if the clinical stroke
type was recorded as undetermined it was recoded to
ischemic or ICH if the discharge ICD-10 code was not I64.
Discharge ICD-10 codes were also used to explore the
principle reason for hospital admission among patients
experiencing in-hospital stroke, and were also used to
develop the Charlson Comorbidity Index14 for patients
where we had information from administrative hospital
records.Process of Care Indicators
All patients with stroke should receive important pro-
cesses of care for which they are eligible. In AuSCR, four
nationally agreed processes of care are collected: admitted
to an SU; received intravenous thrombolysis (for ischemic
stroke); discharged on an antihypertensive agent; and
received a discharge care plan.9 For a subset of patients
from the state of Queensland, four additional processes
have been collected since 2012 and are also reported here:
time to first mobilization, dysphagia screen, aspirin
within 48 hours and being discharged on antiplatelets or
antithrombotics if an ischemic event.Outcome Assessment
We report in-hospital deaths within 7-days, 30-days,
90-days, and 180-days, discharge to home, and length of
stay. For the subset of eligible patients who were
1304 D.A. CADILHAC ET AL.followed-up (i.e. within 180 days of admission, first-
registered event),15 HR-QoL was measured using the
EuroQol (EQ-5D-3L) questionnaire,16 and readmissions,
recurrent strokes, and the modified Rankin Score (from
July 2014) at follow-up were also obtained via self-report.
Individual responses for the EQ5D were converted into a
utility score using the method reported by Viney and col-
leagues.17 This approach was used since it is more respon-
sive for survivors of stroke than using the EQ5D Visual
Analogue Scale score, and incorporates deaths and health
states considered worse than death (e.g. utility score
below zero) as part of the summary measure.18Statistical Analysis
For patient demographic variables, such as age, sex,
and country of birth we only used valid data. Consistent
with standard quality of care monitoring practice, when
data were missing for process of care indicators we
assumed the response was negative to avoid overestima-
tion. Descriptive analyses were used to initially compare
the characteristics of patients by the subgroups of interest.
Pearson x2 tests were used for categorical variables,
and the Kruskal Wallis test was used for the continuous
variables.
Models were adjusted for age, sex, IRSAD, ability to
walk, type of stroke, transfer from another hospital and
documented history of stroke. We included cases trans-
ferred as an independent variable since this group
differed from nontransferred patients: they were more
often male, younger, experienced more severe strokes and
intracerebral hemorrhages, and were more common in
the in-hospital stroke group (14% versus 4% if not trans-
ferred). Regression models were used to investigate differ-
ences in outcomes based on whether or not patients with
in-hospital stroke received management in an SU.
The primary analysis was run on patients with com-
plete (nonimputed) data. Sensitivity analyses were under-
taken using a dataset whereby some variables with >1%
missing and unknown responses were recoded as “no”
for documented history of previous stroke, or “yes” for
“able to walk.” In further sensitivity analyses we also
included the Charlson Comorbidity Index in our models.
Cox proportional hazards regression analysis was used to
calculate differences in the risk of mortality within and up
to 7, 30, 90, and 180 days. The analyses using the 30, 90,
and 180 day time points excluded those who had died at
the previous time point (for example, 30-day analysis
excluded deaths at 7 days, and 90 day analysis excluded
deaths at 30 days). Differences between HR-QoL utility
scores were assessed using median regression to account
for the J-shape distribution. In each model, level or cluster
was defined as hospital to account for potential residual
confounding. All P values were two-sided with P < .05
considered significant for all analyses. Goodness-of-fit
tests including the Pearson Correlation x2 wereundertaken for all our logistic regression models. Where
relevant, we have reported pseudo R2 for each model to
provide an indication of the potential importance of varia-
bles not included in the models on the outcomes of inter-
est, as well as E-values to assess the potential contribution
of unmeasured confounding.19 The analyses were
performed using STATA 12.1 (Statcorp, College Station,
USA, 2014).
Ethics and Patient Consent
Ethics approvals were obtained from all participating
hospitals; Monash University (CF11/3537-2011001884);
and the Australian Institute of Health and Welfare. Con-
sistent with the approach recommended for clinical qual-
ity disease registries to reduce selection bias,20 AuSCR
uses an “opt-out” process plus there is a waiver of consent
for patients who die in hospital.9
Results
Between 2010 and 2014, 20745 episodes of care were
registered in AuSCR for 19,642 individuals from 45 hospi-
tals. Among these episodes, 1182 stroke events (overall
5.1% of total sample) occurred while the patient was in
hospital for another condition. Compared with being
admitted from the community, patients experiencing in-
hospital events were older (median age 77 versus 76 years,
P < .001); more likely to be female (49% versus 46%
P = .06); more often born in Australia or identify as having
an indigenous background and more likely to be able to
walk within 24 hours of stroke onset (38% versus 34%,
P = .001). Type of stroke was similar between groups (see
Supplementary Table e-1). Overall, fewer patients with in-
hospital events compared with community-onset events
accessed an SU (63% versus community-onset 81%;
P < .001) (see Supplementary Table e-2). Other differences
in receiving processes of care, outcomes and discharge
diagnoses between patients with in-hospital events and
community-onset events are available in supplementary
Tables e-2 to e-5. To our knowledge, none of the patients
were treated with mechanical intubation or were treated
with mechanical thrombectomy since this treatment was
still being assessed in clinical trials and this information
was not captured.
Overall, 4389 patients died within 180-days of the
index event, and this was more common among those
with a stroke that occurred while in hospital for another
condition (P < .001). Compared with being admitted
from the community, patients experiencing in-hospital
events were more likely to die within 180 days of
stroke (risk adjusted HR: 1.68: 95% CI: 1.49, 1.89; see
Supplementary Table e-4).
Among the 1182 registered in-hospital events (median
age 77 years, 49% female) from 43 hospitals, demo-
graphics, comorbidities and clinical characteristics were
similar between those treated and not treated in an SU
JMCTD PATIENTS HAVE INCREASED IMT 1305(Table 1). Fewer patients with in-hospital stroke treated in
an SU had an ICH. Patients with an in-hospital event who
were treated in an SU more often received a range of pro-
cesses of care (e.g. mobilized during admission: 79% SU,
52% other wards and intravenous thrombolysis: 14% SU,
6% other wards; Fig 1) and were more often discharged to
rehabilitation (Table 1) compared to those not treated in
an SU.
Compared with patients not treated in an SU, there
were fewer deaths up to 180-days for patients with in-hos-
pital events treated in an SU. In multivariable analyses,
treatment in an SU was associated with a reduced hazard
of death at 7 and 30 days after admission when compared
to patients not treated in an SU (Table 2). Amongst those
who survived to 30 days after admission, there were no
further differences in deaths to 90 days after admission
between those treated in an SU and those treated in an
alternate ward (HR 0.81, 95% CI 0.49-1.32).
Among those who were eligible for follow-up via sur-
vey (61% of patients with in-hospital events; median fol-
low-up time: 101 days, Interquartile range: 97, 107 days),
self-reported readmission to hospital or recurrent stroke
between patients with in-hospital events treated in an SU
and patients treated in other wards was similar (Table 3).
HR-QoL between 90 and 180 days among patients with
in-hospital events treated and not treated in an SU was
similar. In a small subanalysis, patients with in-hospital
events were more likely to report being independent
(mRS 0-2) at 3-6 months follow-up when treated in an SU
(21/39; 54%) than those not treated in an SU (1/8; 13%;
P = .03). Sensitivity analyses indicated that the results
derived from our models were robust for example deaths
up to 7 days: Original model 0.47 (95%CI 0.28, 0.77) with
Charlson Index as a covariate HR: 0.39 (95%CI 0.19, 0.79).Discussion
To our knowledge, this is the first comparison of long-
term outcomes, in terms of mortality (within 180 days)
and HR-QoL (median 101 days), between patients with
in-hospital stroke events treated in an SU or in other
wards. In this large Australian sample, patients with in-
hospital strokes treated in other wards experienced
greater early mortality (within 30 days) than patients
treated in an SU. Amongst those who survived to 30 days
after admission, there was no evidence that treatment in
an SU affected survival to 90 or 180 days, although the dif-
ference in hazard ratio remained when deaths in the first
7 days were included (data not shown). In those who
were followed up between 90 and 180 days after admis-
sion, overall HR-QoL was similar between patients
treated in an SU and those treated in an alternate ward.
Our study also provides evidence that SU care is associ-
ated with increased survival for patients with stroke irre-
spective of whether the onset was in the community or in
hospital.21 This is most likely explained by evidence ofgreater access to evidence-based care as highlighted in the
present study, and complementary evidence from studies
in the United States and Ireland.4,8 There is strong
evidence for a net benefit of thrombolysis for combined
death and dependency, particularly for thrombolysis
administered within 3 hours.22 In the current study,
patients managed in an SU were more likely to receive
acute care interventions such as thrombolysis and aspirin,
and were more often mobilized, received swallow screen-
ing, and prescribed prevention medications at discharge.
These interventions are most often associated with better
outcomes.23-25
Strengths of our study include prospective registration
of a large number of consecutive patients admitted to a
variety of metropolitan and regional areas of Australia.
We also explicitly recorded management in SUs in all
individuals. In other studies of in-hospital stroke, there
has been a reliance on optional reporting of these cases or
a derived location of stroke from administrative data.4
Importantly, the proportion of missing data for in-hospi-
tal stroke in our study was less than 2%. Furthermore,
random auditing of AuSCR hospital data demonstrated
less than 1% discrepancy between auditors on the record-
ing of in-hospital strokes.10 We had >80% power for our
main outcome analyses with 1182 patients with in-hospi-
tal stroke (see Supplemental methods).
Limitations of our study include the potential for selec-
tion or referral bias. That is, less complex patients or those
without competing conditions may have been more often
transferred to an SU. We also acknowledge that we had
limited or incomplete data on comorbidities. In our study,
patients treated in and not in an SU had similar comorbid-
ity profiles, and in a subset of the patients both groups
had a median Charlson comorbidity index of 3. Our
results indicate a larger survival benefit than what was
observed in clinical trials of SU versus general wards2 and
so requires validation. Important predictors of stroke
mortality include age, stroke severity, and pre-existing
conditions such as atrial fibrillation and diabetes.26 In a
recent paper using the AuSCR data13 we highlighted the
importance of using appropriate risk adjustment variables
and methods for comparing mortality outcomes for
stroke, especially the need to account for stroke severity.
Since the AuSCR contains a pragmatic minimum dataset
of variables we were unable to adjust for additional pre-
existing co-morbidities and we were unable to describe
the type of ward where the patient was managed for
patients not admitted to an SU. We acknowledge that
having a limited number of variables to include in our
models could result in important predictors of outcome
being omitted, while too many variables may lead to
overfitting (where false-positive predictors are errone-
ously included in the model), under-fitting, or paradoxical
fitting (where a variable with a positive association with
the outcome is found to have a negative association).11
Consistent with observational designs, unmeasured
Table 1. Demographic and clinical characteristics of patients with in-hospital events according to treatment in a stroke unit
Characteristics SU Non-SU P value
N = 750 N = 432
n (%) n (%)
Female 352/749 (47) 220/428 (51) .15
Age (in years)
Less than 65 145/750 (19) 118/428 (28) .003
65-74 162/750 (22) 91/428 (21)
75-84 267/750 (36) 118/428 (28)
85+ 176/750 (24) 101/428 (24)
Median age in years (Q1, Q3) 78 (69, 85) 76 (64, 85) .024
Australian born 520/750 (69) 299/432 (69) .97
Indigenous background* 14/741 (2) 13/420 (3) .19
Previous stroke 197/703 (28) 87/393 (22) .03
Index of relative socio-economic advantage and disadvantage
Quintile 1 (most disadvantaged) 139/742 (19) 92/424 (22) .007
Quintile 2 178/742 (24) 84/424 (20)
Quintile 3 81/742 (11) 73/424 (17)
Quintile 4 141/742 (19) 81/424 (19)
Quintile 5 (most advantaged) 203/742 (27) 94/424 (22)
Type of stroke
Intracerebral hemorrhage 98/750 (13) 86/432 (20) <.001
Ischemic 626/750 (84) 292/432 (68)
Undetermined stroke 26/750 (4) 54/432 (13)
Stroke severity
Able to walky 253/697 (36) 161/383 (42) .06
Cases with additional administrative data from 2010-2013# N = 262 N = 192
Charlson Comorbidity Index (median) 3 (3, 4) 3 (2, 5) .02
Peripheral vascular disease 4 (2) 13 (5) .11
Congestive heart failure/myocardial infarct 51 (27) 59 (23) .32
Renal or Liver disease 29 (15) 36 (14) .68
Dementia 10 (5) 16 (6) .68
Chronic pulmonary disease 13 (7) 17 (6) .91
Cancer 24 (13) 22 (8) .15
Transfer from another hospital 284/747 (38) 135/428 (32) .03
Median length of stay (days) 11 (6,20) 13 (6,22) .26
Died In Hospital 96/730 (13) 109/417 (26) <.001
Discharge destination
Home 135/634 (21) 98/308 (32) <.001
Rehabilitation 292/634 (46) 106/308 (34) .001
Aged care 44/634 (7) 25/308 (8) .52
SU, Stroke unit.
*Identifies as Aboriginal and/or Torres Strait islander; Q1: 25th percentile; Q3: 75th percentile;
†within first 24 hours of stroke onset;
#patient-level data linked for AuSCR registrants with hospital administrative records for the index admission from New South
Wales, Victoria, Queensland and Western Australia.
1306 D.A. CADILHAC ET AL.confounding is a limitation. The observed estimates could
be explained away by an unmeasured confounder associ-
ated with both SU care and the outcome if the confounder
was of a magnitude equivalent to the E-value estimates
generated (from 1.0 to 11.3) above and beyond the mea-
sured confounding factors, but a weaker confounding fac-
tor could not do so.19
It is plausible that patients with multiple conditions (e.g.
renal failure) could justifiably not be transferred into the
SU as other acute conditions may take priority over stroke
management, or because patients may be perceived as lesslikely to achieve independence following rehabilitation.
However, the benefits of stroke unit care appear to be inde-
pendent of the co-morbidity profile of patients, and in these
circumstances the involvement of the stroke team is still
required.27 It may also be that those transferred to the SU
were less often for palliative care where active intervention
is minimized, but this remains unclear until our data can
be comprehensively linked with administrative records. In
complementary cross-sectional data from the 2015 acute
national audit (»40 cases per hospital in 112 hospitals),28
15% of patients with in-hospital events (23/151) were
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Received thrombolysis, if an ischemic stroke*
Discharged on an anhypertensive medicaon*
Discharged to the community with a care plan
Mobilized during admission*+
Swallow screen or assessment*+
Aspirin within 48 hours,  if an ischemic stroke*+
Discharged on anthromboc medicaon,  if an ischemic
stroke*+
Other wards Stroke unit
Figure 1. Processes of care received by patients with in-hospital stroke managed, or not managed, in stroke units. Legend: *P value < .05; +variables only col-
lected in hospitals located in Queensland.
JMCTD PATIENTS HAVE INCREASED IMT 1307documented as receiving palliative care at some stage dur-
ing their acute hospital stay. Only three of these 23 patients
(13%) receiving palliative care for in hospital stroke were
managed in the SU (unpublished data, Stroke Foundation
2015). These data provide some preliminary evidence that
palliative care may be more often undertaken outside the
stroke unit among these types of patients.
“Ability to walk” may be considered a crude measure
of stroke severity when compared with other popular and
validated methods such as the National Institutes of
Health Stroke Scale, a direct measure of neurological
impairment. However, it is reliable to collect, does not
require certification training, and has been validated inTable 2. Survival analysis of patients with in-hospital
SU Non-SU
Time to death n (%) n (%) P val
Up to 7 days 38/750 (5) 51/432 (12) <.00
8 to 30 days 115/750 (15) 121/432 (28) <.00
31 to 90 days 169/750 (23) 151/432 (35) <.00
91 to 180 days 206/750 (28) 163/432 (38) <.00
CI, confidence interval; HR, hazard ratio; SU, stroke unit (reference ca
*Model adjusted for age, sex, index of relative socioeconomic disa
type of stroke, transfer from another hospital and documented
7 days, 90-day regression excluded deaths up to 30 days, 180-da
ble E-value is 1,19 but there are no specific guidelines on the ra
founding is a threat) and where it is larger (residual confoundi
the minimum strength of association between SU care and the ou
to fully explain away each of the SU care and outcome models lisother stroke populations as reliable for predicting stroke
outcome.11,12 In recent validation work by Sim and col-
leagues the use of simple variables (including ability to
walk) performed similarly well to a model that included
the NIHSS and age.29 We have also shown this variable to
reliably account for differences in patient case-mix when
using the registry data to compare hospital mortality
rates.13 Since 2015 we have also collected the NIHSS in
the registry, but missing data remains an issue. To
account for potential differences in the severity of comor-
bidities known to affect this type of stroke,7 in sensitivity
analyses we included the Charlson Comorbidity Index in
our models and the results were similar.stroke managed and not managed in a stroke unit
Model*
ue HR 95% CI P value E value
1 0.47 0.28, 0.77 .003 2.753
1 0.56 0.39, 0.81 .002 2.350
1 0.81 0.49, 1.32 .396 1.584
1 1.11 0.57, 2.16 .757 1.359
tegory).
dvantage, ability to walk within first 24 hours of stroke onset,
history of stroke. 30-day regression excluded deaths up to
y regression excluded deaths up to 90 days. The lowest possi-
nge of E-values. If an E-value is deemed small (residual con-
ng may not be a problem).30 Therefore, our E-values indicate
tcome that would be required by an unmeasured confounder
ted.
Table 3. Outcomes at 90-180 day follow-up of patients with in-hospital stroke managed and not managed in a stroke unit
SU Non-SU Model*
Follow-up n (%) n (%) P value OR 95% CI P value E-value Pseudo-R2
Readmission 76/305 (25) 30/126 (24) .81 0.79 0.45, 1.37 .40 1.500 0.040
Recurrent stroke 13/305 (4) 3/126 (2) .35 5.92 0.74, 47.0 .09 11.317 0.077
EQ-5D-dimensions
Mobility 155/302 (51) 59/124 (48) .48 1.24 0.78, 1.99 .36 1.469 0.022
Self-care 156/304 (51) 57/125 (46) .28 1.16 0.71, 1.92 .55 1.365 0.048
Usual activities 226/304 (74) 94/125 (75) .85 0.75 0.42, 1.33 .32 1.577 0.057
Pain/discomfort 178/302 (59) 81/125 (65) .26 0.72 0.44, 1.17 .19 1.637 0.023
Anxiety/depression 165/302 (55) 71/123 (58) .56 0.99 0.61, 1.61 .98 1.076 0.020
Median VAS (Q1, Q3) 60 (44,80) 60 (50,77) .62 coefficient 95% CI P value
EQ-5D-3L DCE 0.68 (0.45, 0.80) 0.66 (0.45, 0.79) .99 0.01 -0.06, 0.09 .78 N/A 0.026
CI, confidence interval; OR, odds ratio; Q1, 25th percentile; Q3, 75th percentile; SU, stroke unit (reference category).
*All models are adjusted for age, sex, index of relative socioeconomic advantage and disadvantage, ability to walk within first 24 hours of stroke onset, type of stroke, transfer from
another hospital and documented history of stroke; For assessment of the goodness-of-fit, all P > .05, indicating that the models were a good fit; EQ-5D-3L, EuroQoL -5 dimen-
sion-3 level instrument,16 VAS, Visual Analogue Scale score of the EQ5D; DCE, discrete choice experiment utilities determined using the method by Viney et al. based on the
EQ-5D dimensions.17 The lowest possible E-Value is 1,19 but there are no specific guidelines on the range of E-values. If an E-value is deemed small (residual confounding is a
threat) and where it is larger (residual confounding may not be a problem).30 Therefore, our E-values indicate the minimum strength of association between SU care and the out-
come that would be required by an unmeasured confounder to fully explain away each of the SU care and outcome models listed. Pseudo R2 is a statistic that indicates the preci-
sion of a logistic regression model and can be used to assess the goodness-of-fit in comparison to another model. That is, where the Pseudo R2 value is larger it has a better ability














JMCTD PATIENTS HAVE INCREASED IMT 1309Not all cases of in-hospital strokes may have been cap-
tured in our dataset. Hospital staffs are responsible for pro-
viding data to assess their case ascertainment each year.
When we compared the hospitals with incomplete case
ascertainment to those with 100% case-ascertainment, we
found that the proportion of in-hospital strokes was simi-
lar, ranging from 5%-11% for individual hospitals.
In future research we plan to address some of these lim-
itations by enriching the AuSCR data using data linkage
techniques to merge hospital admissions and emergency
datasets which contain additional information on comor-
bidities, palliative care, procedure codes and hospital care
in an intensive care unit. We will be able to expand the
variables available for case-mix adjustment or other fea-
tures of hospital care without requiring hospital staff to
collect more data.
Conclusion
From this large, multicenter cohort study we observed
an association with treatment in an SU and better early
(within 30-days) survival for patients experiencing a
stroke in hospital compared to their counterparts man-
aged in other types of wards. Although referral bias due
to comorbidity or palliation decisions may contribute to
the observed differences in outcomes; the benefits of SU
care may extend to patients experiencing in-hospital
stroke and where feasible, management in an SU should
be considered. Future work is required to clarify whether
the established benefit of SU care is also applicable to the
subgroup of in-hospital stroke not managed in SUs and
whether engagement of the stroke service team in their
care is of value where transfer is not possible.
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